Biotech RadarJobs updated

COMPANY

RS Oncology

rsoncology.com ↗

Clinical Phase 2

Keywords: oncology small molecule Malignant Pleural Effusion Malignant Pleural Mesothelioma Mesothelioma Mesotheliomas Pleural RSO-021

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1/Phase 2: Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT05278975Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including MesotheliomaPhase 1/Phase 2CompletedMar 31, 2022Nov 30, 2025 (actual)
Feedback